Home Prelude

Prelude

In operation
-
Provider of Molecular Diagnostics and Precision Medical Services for Early-Stage Breast Cancer
Basic
Enterprise Profile

Basic Information

Prelude is a leading personalized breast cancer diagnostics company dedicated to serving breast cancer patients and doctors worldwide. PreludeDx has been committed to developing precise breast cancer tools that impact treatment decisions for patients. Its mission is to provide patients and doctors with innovative technologies to improve patient outcomes and reduce the overall cost burden on the healthcare system.
Prelude Corporation
SanFrancisco,California,United States of America
15~50 people
January 01, 2009
info@preludedx.com

Enterprise Profile

Industrial Sector
Independent Medical Ancillary Services
Technology
Molecular Diagnostics Gene Technology
Concept
Disease Diagnosis Breast Cancer
Application Scenarios
Precision Medicine